Nifty
Sensex
:
:
24741.00
80710.76
6.70 (0.03%)
-7.25 (-0.01%)

Pharmaceuticals & Drugs

Rating :
32/99

BSE: 524280 | NSE: KOPRAN

177.04
05-Sep-2025
  • Open
  • High
  • Low
  • Previous Close
  •  169.94
  •  182.1
  •  167.46
  •  168.92
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  984315
  •  174735230.83
  •  369.7
  •  154.06

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 854.66
  • 24.49
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 976.58
  • 1.69%
  • 1.63

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 44.42%
  • 5.87%
  • 42.83%
  • FII
  • DII
  • Others
  • 0.76%
  • 0.00%
  • 6.12%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.83
  • 5.06
  • 4.55

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.20
  • -2.23
  • 7.07

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.65
  • -8.95
  • 12.29

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.42
  • 19.31
  • 23.02

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.06
  • 2.51
  • 2.14

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.37
  • 12.88
  • 14.24

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
135.22
139.44
-3.03%
172.36
186.08
-7.37%
166.24
158.92
4.61%
151.56
152.59
-0.68%
Expenses
121.09
121.27
-0.15%
155.28
164.39
-5.54%
146.40
135.34
8.17%
136.82
129.76
5.44%
EBITDA
14.13
18.16
-22.19%
17.09
21.69
-21.21%
19.84
23.58
-15.86%
14.74
22.83
-35.44%
EBIDTM
10.45%
13.03%
9.91%
11.66%
11.93%
14.84%
9.72%
14.96%
Other Income
2.56
2.63
-2.66%
3.26
9.67
-66.29%
0.17
2.43
-93.00%
0.99
0.13
661.54%
Interest
2.54
2.18
16.51%
2.77
2.59
6.95%
2.16
2.24
-3.57%
2.23
1.94
14.95%
Depreciation
4.26
3.87
10.08%
3.87
3.59
7.80%
4.00
3.27
22.32%
3.85
2.77
38.99%
PBT
9.89
14.73
-32.86%
13.71
25.18
-45.55%
13.86
20.51
-32.42%
9.64
18.25
-47.18%
Tax
2.44
3.64
-32.97%
4.03
6.56
-38.57%
3.46
4.71
-26.54%
2.26
4.48
-49.55%
PAT
7.45
11.09
-32.82%
9.68
18.62
-48.01%
10.39
15.79
-34.20%
7.38
13.77
-46.41%
PATM
5.51%
7.96%
5.61%
10.01%
6.25%
9.94%
4.87%
9.02%
EPS
1.54
2.30
-33.04%
2.00
3.86
-48.19%
2.16
3.28
-34.15%
1.53
2.86
-46.50%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
625.38
629.60
614.59
550.99
477.52
491.81
359.50
357.90
313.32
309.72
296.32
Net Sales Growth
-1.83%
2.44%
11.54%
15.39%
-2.91%
36.80%
0.45%
14.23%
1.16%
4.52%
 
Cost Of Goods Sold
404.12
376.08
374.40
334.49
248.55
283.34
192.78
190.88
171.87
164.89
166.92
Gross Profit
221.26
253.52
240.19
216.50
228.97
208.47
166.72
167.02
141.44
144.82
129.39
GP Margin
35.38%
40.27%
39.08%
39.29%
47.95%
42.39%
46.38%
46.67%
45.14%
46.76%
43.67%
Total Expenditure
559.59
556.70
540.23
499.19
390.28
410.20
312.80
312.47
284.27
273.60
266.09
Power & Fuel Cost
-
26.45
24.52
23.16
19.27
16.65
18.08
17.10
14.90
13.71
14.10
% Of Sales
-
4.20%
3.99%
4.20%
4.04%
3.39%
5.03%
4.78%
4.76%
4.43%
4.76%
Employee Cost
-
60.54
52.28
49.95
43.27
37.16
36.85
37.11
32.24
31.37
28.02
% Of Sales
-
9.62%
8.51%
9.07%
9.06%
7.56%
10.25%
10.37%
10.29%
10.13%
9.46%
Manufacturing Exp.
-
47.13
45.34
42.67
38.78
33.89
30.06
32.41
31.35
31.84
27.80
% Of Sales
-
7.49%
7.38%
7.74%
8.12%
6.89%
8.36%
9.06%
10.01%
10.28%
9.38%
General & Admin Exp.
-
32.28
29.56
27.86
28.23
26.35
20.99
18.92
19.20
16.93
15.68
% Of Sales
-
5.13%
4.81%
5.06%
5.91%
5.36%
5.84%
5.29%
6.13%
5.47%
5.29%
Selling & Distn. Exp.
-
8.81
9.40
9.31
8.54
8.42
9.36
9.18
9.56
8.46
9.35
% Of Sales
-
1.40%
1.53%
1.69%
1.79%
1.71%
2.60%
2.56%
3.05%
2.73%
3.16%
Miscellaneous Exp.
-
5.43
4.72
11.77
3.64
4.40
4.69
6.86
5.15
6.39
9.35
% Of Sales
-
0.86%
0.77%
2.14%
0.76%
0.89%
1.30%
1.92%
1.64%
2.06%
1.42%
EBITDA
65.80
72.90
74.36
51.80
87.24
81.61
46.70
45.43
29.05
36.12
30.23
EBITDA Margin
10.52%
11.58%
12.10%
9.40%
18.27%
16.59%
12.99%
12.69%
9.27%
11.66%
10.20%
Other Income
6.98
3.98
14.67
3.06
10.76
18.15
0.63
3.96
10.94
10.66
2.37
Interest
9.70
9.34
8.59
6.08
5.12
6.24
8.91
8.99
8.60
13.70
12.56
Depreciation
15.98
15.59
12.89
12.71
11.10
10.19
9.58
8.74
8.51
8.33
8.12
PBT
47.10
51.95
67.54
36.07
81.78
83.34
28.84
31.66
22.89
24.76
11.91
Tax
12.19
13.40
16.59
8.83
20.75
21.73
7.26
7.64
2.40
4.85
0.00
Tax Rate
25.88%
25.79%
24.56%
24.48%
25.37%
26.07%
25.66%
24.13%
10.48%
19.59%
0.00%
PAT
34.90
38.55
50.96
27.23
61.03
61.61
21.02
24.02
20.49
19.91
10.72
PAT before Minority Interest
34.90
38.55
50.96
27.23
61.03
61.61
21.02
24.02
20.49
19.91
10.72
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
5.58%
6.12%
8.29%
4.94%
12.78%
12.53%
5.85%
6.71%
6.54%
6.43%
3.62%
PAT Growth
-41.12%
-24.35%
87.15%
-55.38%
-0.94%
193.10%
-12.49%
17.23%
2.91%
85.73%
 
EPS
7.23
7.98
10.55
5.64
12.64
12.76
4.35
4.97
4.24
4.12
2.22

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
518.35
491.25
439.25
426.17
245.03
189.68
168.48
144.71
124.67
108.72
Share Capital
48.29
48.21
48.21
48.21
43.25
43.25
43.25
43.25
43.25
51.83
Total Reserves
468.45
442.00
391.04
377.96
201.78
146.43
125.23
101.46
81.42
56.89
Non-Current Liabilities
36.70
33.47
33.48
33.13
33.67
40.48
46.17
31.45
32.17
33.00
Secured Loans
2.04
0.45
0.65
0.15
0.33
0.15
0.28
0.44
0.33
0.33
Unsecured Loans
14.45
16.16
17.24
18.62
20.88
31.68
40.84
29.48
32.17
28.36
Long Term Provisions
10.89
9.00
8.51
8.09
7.47
7.20
6.42
5.14
4.59
4.31
Current Liabilities
288.97
218.53
176.97
151.59
160.68
140.05
134.71
135.53
136.49
122.08
Trade Payables
119.41
113.09
87.38
62.30
85.91
54.74
51.16
60.67
47.13
57.04
Other Current Liabilities
38.86
22.80
32.85
31.40
28.85
38.17
35.24
21.30
29.91
26.64
Short Term Borrowings
129.06
81.02
55.51
53.71
43.08
46.23
45.44
52.11
56.09
38.00
Short Term Provisions
1.63
1.63
1.23
4.17
2.84
0.91
2.87
1.45
3.36
0.41
Total Liabilities
844.02
743.25
649.70
610.89
439.38
370.21
349.36
311.69
293.33
263.80
Net Block
208.41
181.71
164.99
150.69
112.19
111.15
112.62
104.44
104.47
100.88
Gross Block
305.55
263.45
233.83
206.81
157.31
146.31
138.14
121.27
112.80
314.06
Accumulated Depreciation
97.14
81.74
68.84
56.12
45.12
35.16
25.52
16.84
8.33
213.18
Non Current Assets
334.26
289.22
250.63
196.01
162.43
147.61
141.79
118.20
113.62
109.78
Capital Work in Progress
113.20
96.59
69.58
35.55
42.89
30.24
24.29
9.93
6.29
3.13
Non Current Investment
0.06
0.06
0.06
0.06
0.05
0.02
0.02
0.05
0.05
0.11
Long Term Loans & Adv.
11.03
9.11
14.33
8.19
6.09
4.90
3.54
2.47
2.30
5.61
Other Non Current Assets
1.57
1.75
1.67
1.53
1.22
1.29
1.32
1.31
0.50
0.03
Current Assets
509.75
454.03
399.07
414.87
276.95
222.60
207.57
193.50
179.72
154.01
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
169.42
138.49
130.61
149.94
100.00
88.50
73.45
71.01
60.56
58.84
Sundry Debtors
214.93
212.33
162.56
127.36
120.08
92.81
86.64
64.77
73.11
56.89
Cash & Bank
25.86
14.20
12.58
57.13
6.90
4.75
3.96
6.18
6.88
4.71
Other Current Assets
99.53
6.32
5.77
4.89
49.97
36.55
43.52
51.54
39.16
33.58
Short Term Loans & Adv.
94.54
82.70
87.55
75.55
44.14
34.26
37.98
47.57
37.33
32.65
Net Current Assets
220.78
235.50
222.10
263.29
116.26
82.55
72.85
57.96
43.23
31.93
Total Assets
844.01
743.25
649.70
610.88
439.38
370.21
349.36
311.70
293.34
263.79

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
41.94
43.26
34.02
-33.48
59.95
31.00
25.41
25.77
15.87
28.63
PBT
51.95
67.54
36.07
81.78
83.34
28.84
31.66
22.89
24.76
10.72
Adjustment
24.80
20.96
16.29
13.82
16.44
21.63
13.35
13.52
25.15
19.63
Changes in Working Capital
-21.56
-30.91
-5.55
-110.81
-23.79
-11.77
-15.72
-7.56
-33.13
-1.71
Cash after chg. in Working capital
55.19
57.59
46.81
-15.21
75.98
38.70
29.30
28.84
16.78
28.64
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-13.25
-14.33
-12.79
-18.27
-16.03
-7.15
-3.88
-3.07
-0.91
-0.01
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
-0.55
0.00
0.00
0.00
0.00
Cash From Investing Activity
-56.43
-43.55
-12.65
-84.42
-25.28
-12.52
-24.86
-10.96
-17.96
-9.07
Net Fixed Assets
-16.95
-10.46
-5.97
-3.31
-4.35
-4.86
-5.66
-5.43
35.65
-4.54
Net Investments
-1.80
-1.20
-0.64
-100.64
-0.65
-0.62
-0.60
-0.32
-0.53
-110.00
Others
-37.68
-31.89
-6.04
19.53
-20.28
-7.04
-18.60
-5.21
-53.08
105.47
Cash from Financing Activity
25.87
0.99
-19.84
122.82
-34.57
-18.06
-0.58
-15.02
1.97
-19.34
Net Cash Inflow / Outflow
11.38
0.69
1.53
4.93
0.10
0.42
-0.03
-0.21
-0.12
0.22
Opening Cash & Equivalents
8.09
7.40
5.87
0.94
0.83
0.41
0.44
0.66
0.78
0.56
Closing Cash & Equivalent
19.47
8.09
7.40
5.87
0.94
0.83
0.41
0.44
0.66
0.78

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
107.02
101.68
91.11
88.40
56.65
43.86
38.95
33.46
28.83
23.15
ROA
4.86%
7.32%
4.32%
11.62%
15.22%
5.84%
7.27%
6.77%
7.15%
3.98%
ROE
7.66%
10.96%
6.29%
18.19%
28.34%
11.74%
15.34%
15.21%
17.71%
12.19%
ROCE
9.75%
13.78%
8.30%
21.40%
30.40%
13.69%
16.30%
13.88%
19.24%
13.09%
Fixed Asset Turnover
2.21
2.47
2.53
2.66
3.30
2.54
2.76
2.69
1.49
0.98
Receivable days
123.83
111.32
94.82
93.20
77.53
90.59
77.21
79.96
74.44
82.54
Inventory Days
89.24
79.90
91.76
94.14
68.65
81.75
73.66
76.30
68.37
62.26
Payable days
112.82
97.72
81.67
108.83
90.60
60.78
68.76
72.54
73.61
89.54
Cash Conversion Cycle
100.24
93.50
104.91
78.51
55.58
111.55
82.11
83.72
69.21
55.25
Total Debt/Equity
0.29
0.20
0.17
0.17
0.27
0.47
0.58
0.61
0.76
0.65
Interest Cover
6.56
8.86
6.93
16.98
14.36
4.17
4.52
3.66
2.81
1.85

News Update:


  • Kopran - Quarterly Results
    29th Jul 2025, 14:19 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.